DBV Technologies (DBVT) Prepaid Assets (2015 - 2026)
DBV Technologies (DBVT) posted quarterly Prepaid Assets of $27.0 million for Q2 2026, up 49.72% year-on-year from $18.0 million in Q2 2025, and up 54.29% on a QoQ basis from $17.5 million in Q1 2026.
DBV Technologies (DBVT) Prepaid Assets (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Prepaid Assets for 12 consecutive years, with $27.0 million the latest figure, recorded in Q2 2026.
- Quarterly Prepaid Assets rose 49.72% year-over-year to $27.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $27.0 million (up 49.72% YoY) and the FY2025 annual result came in at $18.8 million, up 57.56% from the prior year.
- Prepaid Assets advanced to $27.0 million in Q2 2026 per DBVT's latest filing, from $17.5 million in the prior quarter.
- Over the last five years, Prepaid Assets for DBVT reached as high as $27.0 million in Q2 2026 and fell as low as $11.9 million in Q4 2024.
- A 5-year average of $18.1 million and a median of $18.0 million in 2023 frame the typical range for Prepaid Assets.
- The largest YoY upside for Prepaid Assets was 122.19% in 2022 against a maximum downside of 62.57% in 2022.
- Year by year, Prepaid Assets stood at $13.9 million in 2022, then increased by 26.43% to $17.5 million in 2023, then plunged by 32.0% to $11.9 million in 2024, then surged by 57.56% to $18.8 million in 2025, then surged by 43.62% to $27.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $27.0 million, $17.5 million, and $18.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.00 Mn |
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 18.80 Mn |
| Sep 30, 2025 | 19.05 Mn |
| Jun 30, 2025 | 18.03 Mn |
| Mar 31, 2025 | 16.19 Mn |
| Dec 31, 2024 | 11.93 Mn |
| Sep 30, 2024 | 22.32 Mn |
| Jun 30, 2024 | 23.75 Mn |
| Mar 31, 2024 | 18.04 Mn |
| Dec 31, 2023 | 17.55 Mn |
| Sep 30, 2023 | 20.14 Mn |
| Jun 30, 2023 | 21.58 Mn |
| Mar 31, 2023 | 17.95 Mn |
| Dec 31, 2022 | 13.88 Mn |
| Sep 30, 2022 | 13.03 Mn |
| Jun 30, 2022 | 11.98 Mn |
| Mar 31, 2022 | 16.33 Mn |
| Dec 31, 2021 | 37.09 Mn |
| Sep 30, 2021 | 11.94 Mn |